Shimadzu Corp is a Japan-based company engaged in the manufacture of precision instruments, measuring equipment, and medical devices. The firm operates in four segments: Aviation Equipment, Industrial Equipment, Measuring Equipment, Medical Equipment, and Others. It generates the majority of its revenue from the Measuring Equipment segment, which is engaged in the provision of X-ray television (TV) systems, angiography systems, X-ray imaging systems, and others.
1875
16.2K+
LTM Revenue $3.6B
LTM EBITDA $590M
$6.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
As of September 2025, Shimadzu reported last 12-month revenue of $3.6B and EBITDA of $590M.
In the same period, Shimadzu generated $1.6B in LTM gross profit and $344M in net income.
See Shimadzu valuation multiples based on analyst estimatesIn the most recent fiscal year, Shimadzu reported revenue of $3.5B and EBITDA of $603M.
Shimadzu expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Shimadzu valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $3.6B | XXX | $3.5B | XXX | XXX | XXX |
Gross Profit | $1.6B | XXX | $1.5B | XXX | XXX | XXX |
Gross Margin | 44% | XXX | 43% | XXX | XXX | XXX |
EBITDA | $590M | XXX | $603M | XXX | XXX | XXX |
EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
EBIT | $460M | XXX | $470M | XXX | XXX | XXX |
EBIT Margin | 13% | XXX | 13% | XXX | XXX | XXX |
Net Profit | $344M | XXX | $353M | XXX | XXX | XXX |
Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Shimadzu has current market cap of JPY 1.13T (or $7.4B), and EV of JPY 1.00T (or $6.6B).
As of October 17, 2025, Shimadzu's stock price is JPY 3917 (or $26).
See Shimadzu trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$6.6B | $7.4B | XXX | XXX | XXX | XXX | $1.18 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialShimadzu's trades at 1.9x EV/Revenue multiple, and 10.8x EV/EBITDA.
See valuation multiples for Shimadzu and 15K+ public compsAs of October 17, 2025, Shimadzu has market cap of $7.4B and EV of $6.6B.
Equity research analysts estimate Shimadzu's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Shimadzu has a P/E ratio of 21.6x.
LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $7.4B | XXX | $7.4B | XXX | XXX | XXX |
EV (current) | $6.6B | XXX | $6.6B | XXX | XXX | XXX |
EV/Revenue | 1.9x | XXX | 1.9x | XXX | XXX | XXX |
EV/EBITDA | 11.2x | XXX | 10.8x | XXX | XXX | XXX |
EV/EBIT | 14.3x | XXX | 14.0x | XXX | XXX | XXX |
EV/Gross Profit | 4.2x | XXX | n/a | XXX | XXX | XXX |
P/E | 21.6x | XXX | 20.7x | XXX | XXX | XXX |
EV/FCF | 26.8x | XXX | 32.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialShimadzu's last 12 month revenue growth is 2%
Shimadzu's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Shimadzu's rule of 40 is 20% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Shimadzu's rule of X is 23% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Shimadzu and other 15K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 2% | XXX | 2% | XXX | XXX | XXX |
EBITDA Margin | 17% | XXX | 17% | XXX | XXX | XXX |
EBITDA Growth | 4% | XXX | 1% | XXX | XXX | XXX |
Rule of 40 | 20% | XXX | 20% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 23% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 30% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Shimadzu acquired XXX companies to date.
Last acquisition by Shimadzu was XXXXXXXX, XXXXX XXXXX XXXXXX . Shimadzu acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free TrialWhen was Shimadzu founded? | Shimadzu was founded in 1875. |
Where is Shimadzu headquartered? | Shimadzu is headquartered in Japan. |
How many employees does Shimadzu have? | As of today, Shimadzu has 16.2K+ employees. |
Who is the CEO of Shimadzu? | Shimadzu's CEO is Mr. Yasunori Yamamoto. |
Is Shimadzu publicy listed? | Yes, Shimadzu is a public company listed on TKS. |
What is the stock symbol of Shimadzu? | Shimadzu trades under 7701 ticker. |
When did Shimadzu go public? | Shimadzu went public in 1949. |
Who are competitors of Shimadzu? | Similar companies to Shimadzu include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Shimadzu? | Shimadzu's current market cap is $7.4B |
What is the current revenue of Shimadzu? | Shimadzu's last 12 months revenue is $3.6B. |
What is the current revenue growth of Shimadzu? | Shimadzu revenue growth (NTM/LTM) is 2%. |
What is the current EV/Revenue multiple of Shimadzu? | Current revenue multiple of Shimadzu is 1.9x. |
Is Shimadzu profitable? | Yes, Shimadzu is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Shimadzu? | Shimadzu's last 12 months EBITDA is $590M. |
What is Shimadzu's EBITDA margin? | Shimadzu's last 12 months EBITDA margin is 17%. |
What is the current EV/EBITDA multiple of Shimadzu? | Current EBITDA multiple of Shimadzu is 11.2x. |
What is the current FCF of Shimadzu? | Shimadzu's last 12 months FCF is $246M. |
What is Shimadzu's FCF margin? | Shimadzu's last 12 months FCF margin is 7%. |
What is the current EV/FCF multiple of Shimadzu? | Current FCF multiple of Shimadzu is 26.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.